On March 27, 2026, Certara, Inc. announced that Cynthia Collins, a member of its Board of Directors and the Audit Committee, has notified the company of her intention to resign as a Class II director. Her resignation will take effect on May 14, 2026, coinciding with the date of the company's 2026 annual meeting of stockholders. Ms. Collins has indicated that her decision to resign is not due to any disagreement with the company regarding its operations, policies, or practices. The company will continue to operate under its current governance structure and will seek to fill the vacancy created by her departure. This change in the board composition is part of the company's ongoing efforts to ensure effective governance and oversight as it navigates its strategic objectives in the biopharmaceutical sector. Certara remains committed to maintaining a diverse and experienced board to guide its future endeavors.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.